Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
GOUNDER, Mrinal M, LEFKOWITZ, Robert A, KEOHAN, Mary Louise, D'ADAMO, David R, HAMEED, Meera, ANTONESCU, Cristina R, SINGER, Samuel, STOUT, Katherine, AHN, Linda, MAKI, Robert G
Published in Clinical cancer research (15.06.2011)
Published in Clinical cancer research (15.06.2011)
Get full text
Journal Article
Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas
Elkrief, Arielle, Makhnin, Alex, Moses, Khadeja A, Ahn, Linda S, Preeshagul, Isabel R, Iqbal, Afsheen N, Hayes, Sara A, Plodkowski, Andrew J, Paik, Paul K, Ladanyi, Marc, Kris, Mark G, Riely, Gregory J, Michor, Franziska, Yu, Helena A
Published in Clinical cancer research (14.04.2023)
Published in Clinical cancer research (14.04.2023)
Get full text
Journal Article
Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor)
de Camargo, Veridiana Pires, Keohan, Mary L., D'Adamo, David R., Antonescu, Cristina R., Brennan, Murray F., Singer, Samuel, Ahn, Linda S., Maki, Robert G.
Published in Cancer (01.05.2010)
Published in Cancer (01.05.2010)
Get full text
Journal Article
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
Paik, Paul K, Luo, Jia, Ai, Ni, Kim, Rachel, Ahn, Linda, Biswas, Anup, Coker, Courtney, Ma, Wanchao, Wong, Phillip, Buonocore, Darren J, Lai, W Victoria, Chaft, Jamie E, Acharyya, Swarnali, Massagué, Joan, Kris, Mark G
Published in Nature communications (15.10.2022)
Published in Nature communications (15.10.2022)
Get full text
Journal Article
Pilot Study of Dacomitinib for Patients With Metastatic EGFR -Mutant Lung Cancers With Disease Progression After Initial Treatment With Osimertinib
Choudhury, Noura J, Makhnin, Alex, Tobi, Yosef Y, Daly, Robert M, Preeshagul, Isabel R, Iqbal, Afsheen N, Ahn, Linda S, Hayes, Sara A, Heller, Glenn, Kris, Mark G, Riely, Gregory J, Yu, Helena A
Published in JCO precision oncology (2021)
Published in JCO precision oncology (2021)
Get more information
Journal Article
Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations
Arbour, Kathryn C., Manchado, Eusebio, Bott, Matthew J., Ahn, Linda, Tobi, Yosef, Ni, Andy Ai, Yu, Helena A., Shannon, Alyssa, Ladanyi, Marc, Perron, Victoria, Ginsberg, Michelle S., Johnson, Amanda, Holodny, Andrei, Kris, Mark G., Rudin, Charles M., Lito, Piro, Rosen, Neal, Lowe, Scott, Riely, Gregory J.
Published in JTO clinical and research reports (01.01.2022)
Published in JTO clinical and research reports (01.01.2022)
Get full text
Journal Article
Consumptive Coagulopathy in Angiosarcoma: A Recurrent Phenomenon?
Cioffi, Angela, Brohl, Andrew, Ahn, Linda, Farid, Mohamad, Maki, Robert G.
Published in Complexity (New York, N.Y.) (2014)
Published in Complexity (New York, N.Y.) (2014)
Get full text
Journal Article
Tepotinib: Guidance for oncology nurses on management of adverse events in patients with MET exon 14 skipping non-small-cell lung cancer
Ahn, Linda, Alexander, Terri, Vlassak, Soetkin, Berghoff, Karin, Lemmens, Liesbeth
Published in Clinical journal of oncology nursing (15.09.2022)
Published in Clinical journal of oncology nursing (15.09.2022)
Get full text
Journal Article
Osimertinib, platinum, etoposide as initial treatment for patients with EGFR mutant lung cancers with TP53 and RB1 alterations
Chen, Monica F, Rakhade, Swanand, Quintanal-Villalonga, Alvaro, Lee, Jake, Forsythe, Britney, Moses, Khadeja A., Ahn, Linda Su Hyun, Pupo, Amanda, Falcon, Christina J., Rekhtman, Natasha, Kris, Mark G., Rudin, Charles M., Chan, Joseph Minhow, Yu, Helena Alexandra
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
Paik, Paul K., Fan, Pang-Dian, Qeriqi, Besnik, Namakydoust, Azadeh, Daly, Bobby, Ahn, Linda, Kim, Rachel, Plodkowski, Andrew, Ni, Ai, Chang, Jason, Fanaroff, Rachel, Ladanyi, Marc, de Stanchina, Elisa, Rudin, Charles M.
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article
Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic EGFR-Mutant Lung Cancers: A Phase 1/2 Single-Group Open-Label Trial
Yu, Helena A, Schoenfeld, Adam J, Makhnin, Alex, Kim, Rachel, Rizvi, Hira, Tsui, Dana, Falcon, Christina, Houck-Loomis, Brian, Meng, Fanli, Yang, Julie Li, Tobi, Yosef, Heller, Glenn, Ahn, Linda, Hayes, Sara A, Young, Robert J, Arcila, Maria E, Berger, Michael, Chaft, Jamie E, Ladanyi, Marc, Riely, Gregory J, Kris, Mark G
Published in JAMA oncology (01.07.2020)
Published in JAMA oncology (01.07.2020)
Get more information
Journal Article
A phase 2 study of amivantamab plus lazertinib in patients with EGFR- mutant lung cancer and active central nervous system disease
Yu, Helena Alexandra, Chen, Monica F, Hui, Angela B., Choudhury, Noura J., Lee, Jake June-Koo, Zheng, Jennifer, Ahn, Linda Su Hyun, Pupo, Amanda, Nesselbush, Monica, Jabara, Isabel, Heller, Glenn, Arbour, Kathryn C., Santini, Fernando Costa, Offin, Michael, Chaft, Jamie E., Young, Robert J., Riely, Gregory J., Kris, Mark G., Diehn, Maximilian, Boire, Adrienne Ann
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas
Schilsky, Juliana B, Ni, Ai, Ahn, Linda, Datta, Sutirtha, Travis, William D, Kris, Mark G, Chaft, Jamie E, Rekhtman, Natasha, Hellmann, Matthew D
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2017)
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2017)
Get full text
Journal Article
Targeting NFE2L2/KEAP1 mutations in advanced non-small cell lung cancer with the TORC1/2 inhibitor TAK-228
Paik, Paul K., Fan, Pang-Dian, Qeriqi, Besnik, Namakydoust, Azadeh, Daly, Bobby, Ahn, Linda, Kim, Rachel, Plodkowski, Andrew, Ni, Ai, Chang, Jason, Fanaroff, Rachel, Ladanyi, Marc, de Stanchina, Elisa, Rudin, Charles M.
Published in Journal of thoracic oncology (12.10.2022)
Published in Journal of thoracic oncology (12.10.2022)
Get full text
Journal Article
A phase 1/2 study of osimertinib and bevacizumab as initial treatment for patients with metastatic EGFR-mutant lung cancers
Yu, Helena Alexandra, Kim, Rachel, Makhnin, Alex, Ahn, Linda Su Hyun, Ni, Ai, Hayes, Sara A., Young, Robert J., Riely, Gregory J., Kris, Mark G.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
Paik, Paul K., Ahn, Linda Su Hyun, Ginsberg, Michelle S., Plodkowski, Andrew J., Kim, Rachel, Doyle, L. Austin, Rudin, Charles M.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Twice weekly pulse and daily continuous‐dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
Arbour, Kathryn C., Kris, Mark G., Riely, Gregory J., Ni, Ai, Beal, Kathryn, Daras, Mariza, Hayes, Sara A., Young, Robert J., Rodriguez, Christopher R., Ahn, Linda, Pao, William, Yu, Helena A.
Published in Cancer (01.01.2018)
Published in Cancer (01.01.2018)
Get full text
Journal Article
Targeting NFE2L2 mutations in advanced squamous cell lung cancers with the TORC1/2 inhibitor TAK228
Paik, Paul K., Qeriqi, Besnik, Ahn, Linda Su Hyun, Ginsberg, Michelle S., Tandon, Nidhi, McFarland, Daniel, Doyle, L. Austin, de Stanchina, Elisa, Rudin, Charles M.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article